These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 2570631

  • 1. Cardioprotective effect of metipranolol on ischemic heart muscle.
    Gvozdják J, Gvozdjáková A, Kucharská J, Bada V.
    Cardiology; 1989; 76(3):206-10. PubMed ID: 2570631
    [Abstract] [Full Text] [Related]

  • 2. [The effect of trimepranol on metabolism in the ischemic heart muscle].
    Gvozdják J, Gvozdjáková A, Kucharská J, Bada V, Baranyai A, Drímal J.
    Vnitr Lek; 1985 Mar; 31(3):209-15. PubMed ID: 2863890
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G, Voss E, Dietmann K.
    Med Welt; 1981 Apr 07; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of nitroglycerin and sodium nitrite on myocardial mitochondrial respiration and oxidative phosphorylation normally and in coronarogenic ischemia].
    Urakov AL.
    Farmakol Toksikol; 1979 Apr 07; 42(6):621-4. PubMed ID: 115709
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical and metabolic effects of metipranolol].
    Cottini E, Barbanti P, Lunetta M, Dimaiuta G, Emma V, Sorrentino F.
    Boll Soc Ital Cardiol; 1981 Apr 07; 26(10):1341-8. PubMed ID: 6129875
    [No Abstract] [Full Text] [Related]

  • 7. [Changes in the efficiency of the left heart ventricle during treatment with metipranolol (Trimepranol Spofa)].
    Smíd J, Hůla J, Kubín Z.
    Vnitr Lek; 1983 Apr 07; 29(4):325-31. PubMed ID: 6135276
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of metipranolol (Trimepranol Spofa) on changes in selected hemodynamic indicators during physical exercise. II. Isometric loading].
    Smíd J, Kubín Z.
    Vnitr Lek; 1983 Sep 07; 29(9):869-75. PubMed ID: 6138900
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
    Ceremuzynski L, Zaleska T, Nauman J, Nauman A, Zalewski A.
    Int J Clin Pharmacol Biopharm; 1979 Jun 07; 17(6):244-9. PubMed ID: 38215
    [Abstract] [Full Text] [Related]

  • 12. Effect of betamethasone on mitochondrial oxidative phosphorylation in ischemic canine myocardium.
    Sunamori M, Harrison CE.
    Mayo Clin Proc; 1980 Jun 07; 55(6):377-82. PubMed ID: 7382546
    [Abstract] [Full Text] [Related]

  • 13. Prevention of sudden death in acute myocardial ischaemia.
    Fejfar Z, Vrána M, Horák O, Trcka V, Kristan L, Blazek Z, Korál V, Sychra T.
    Czech Med; 1980 Jun 07; 3(1):28-35. PubMed ID: 6102022
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
    Vavrejnová V, Felt V, Nedvídková J.
    Cas Lek Cesk; 1985 Oct 25; 124(43):1320-3. PubMed ID: 2867827
    [No Abstract] [Full Text] [Related]

  • 15. Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion.
    Nagao T, Matlib MA, Franklin D, Millard RW, Schwartz A.
    J Mol Cell Cardiol; 1980 Jan 25; 12(1):29-43. PubMed ID: 7359589
    [No Abstract] [Full Text] [Related]

  • 16. Preservation of oxidative phosphorylation by lidocaine in ischemic and reperfused myocardium.
    Baron DW, Sunamori M, Harrison CE.
    Adv Myocardiol; 1983 Jan 25; 4():567-73. PubMed ID: 6856981
    [Abstract] [Full Text] [Related]

  • 17. [Metipranolol in the prevention of intraocular pressure elevation after cataract extraction].
    Schmitz-Valckenberg P.
    Klin Monbl Augenheilkd; 1983 Feb 25; 182(2):150-2. PubMed ID: 6133027
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of propranolol on myocardial oxidative processes.
    Bada V, Gvozdják A, Krutý F, Niederland TR, Gvozdják J.
    Cor Vasa; 1979 Feb 25; 21(3):215-20. PubMed ID: 535407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.